Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M280Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M280EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %1.2Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with PJP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

PJP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PJP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Kushniruk, David10% Security Holder, Director 2014-12-17Buy329,000$0.0975233.33view
Allen, JasonDirector, Senior Officer 2014-12-16Buy225,000$0.1448328.57view
O'Keeffe, William MichaelDirector 2014-12-16Buy100,000$0.1545100view
O'Keeffe, William MichaelDirector 2014-12-16Buy55,000$0.1545100view
O'Keeffe, William MichaelDirector 2014-12-16Buy500,000$0.1545100view
Lacoste, Jean-MarcDirector, Senior Officer 2014-12-16Buy15,500$0.1256400view
Lacoste, Jean-MarcDirector, Senior Officer 2014-12-16Buy12,500$0.1256400view
Lacoste, Jean-MarcDirector, Senior Officer 2014-12-16Buy2,000$0.1352053.85view
Sangha, Gurminder SinghDirector 2014-12-16Buy1,000$0.02338900view
mccartney, william davidDirector, Senior Officer 2014-12-16Buy0$0.4514966.67view

Press Releases about PJP :

    Quarterly/Annual Reports about PJP:

      News about PJP:

      Articles On GuruFocus.com

      More From Other Websites
      PowerShares Multi-Strategy Alternative Portfolio (LALT) Receives William F. Sharpe Award for ETF... Dec 17 2014
      Bio-Twitter Sentiment Favors European Orexigen Obesity Pill Approval Dec 17 2014
      Viekirax/Exviera vs. Harvoni: Clash of the Hep C Drugs 2015 Dec 16 2014
      Invesco PowerShares Provides Estimated Capital Gains Information for 2014 Dec 12 2014
      Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals Dec 12 2014
      Winning: Smart Beta ETFs Keep Gaining Traction Dec 02 2014
      Short Covering Could be Next Catalyst for Health Care ETFs Nov 24 2014
      Invesco PowerShares Expands Industry Leading Smart Beta Suite With a Broad-Based Commodity Strategy... Nov 07 2014
      Biotech Exposure Powers Pharma ETF to New Highs Oct 24 2014
      Drug ETFs Attractive Buys On Pullback Oct 22 2014
      Some ETFs Saying a Salix Takeover Could be Afoot Oct 03 2014
      A Fabulous Pharma ETF Sep 15 2014
      Invesco PowerShares Expands Smart Beta Fixed Income Lineup With Laddered Corporate Bond Portfolio... Sep 10 2014
      The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals... Aug 25 2014
      Pharma ETF Investing 101 Aug 21 2014
      Some ETFs Salivating for a Salix Takeover Aug 20 2014
      Pharma ETFs in Focus on String of Earnings Beat Jul 30 2014
      Dynamic And Durable Growth (Part 1) Jul 24 2014
      Sector Performance Update - First Half 2014 Jul 22 2014
      Invesco PowerShares Announces Changes for Municipal Bond ETFs Jul 08 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK